Published in Drug Law Weekly, March 6th, 2007
"We respectfully disagree that there is any scientific basis to support the jury's finding of a causal link between Wyeth's hormone therapies and the plaintiff's breast cancer," says Barbara R. Binis, a partner with Reed Smith LLP, a firm representing Wyeth in the case. "Further, the evidence established that Wyeth acted responsibly by performing and supporting studies that examined the known and potential benefits and risks of hormone therapy and by keeping...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.